• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重发热伴血小板减少综合征患者中 EB 病毒感染的早期预测因子。

Early predictors of Epstein-Barr virus infection in patients with severe fever with thrombocytopenia syndrome.

机构信息

Department of Infectious Disease, the First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.

Department of Infectious Disease, Division of Life Sciences and Medicine, the First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China.

出版信息

Virol J. 2024 Aug 7;21(1):179. doi: 10.1186/s12985-024-02452-5.

DOI:10.1186/s12985-024-02452-5
PMID:39107822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11304918/
Abstract

BACKGROUND

Epstein-Barr virus (EBV) can be reactivated and proliferated with fatal outcome in immuno-compromised people, but the clinical consequences of EBV infection in patients with severe fever with thrombocytopenia syndrome (SFTS) remain uncertain. In this study, we investigated the infection rate, the influence and the early predictors of EBV infection in SFTS patients.

METHODS

In this retrospective study, SFTS patients who were treated in the First Affiliated Hospital of Nanjing Medical University from May 2011 to August 2021 were enrolled and divided into infected and non-infected groups. We compared the demographic characteristics, clinical manifestations and signs, laboratory tests and prognosis, and explored the risk factors of EBV infection by receiver operating characteristic (ROC) curve and logistic regression.

RESULTS

A total of 120 hospitalized SFTS patients with EBV-DNA testing were enrolled in this study. Patients with EBV infection had statistically significant higher mortality rate (32.0% vs. 11.43%, P = 0.005). Compared with the non-infected group, the EBV-infected group had higher levels of C-reactive protein (CRP), creatine-kinase (CK), fasting blood glucose (FBG), blood urea nitrogen (BUN), D-dimer, and CD56 cell counts, lower levels of immunoglobulin G (IgG), IgM, complement 3 (C3), and C4. The proportion of patients with age ≥ 60 years and ferritin > 1500.0 ng/ml in the EBV-infected group was significantly higher than that in the non-infected group. The results of ROC analysis showed that the cut-off values of CRP, IgG, C3, C4, and CD56 cell counts to predict EBV infection were 13.2 mg/l, 12.5 g/l, 1.1 g/l, 0.6 g/l, 0.3 g/l, and 94.0 cells/µl. Multivariable logistic analysis showed that age ≥ 60 years old, CRP > 13.2 mg/l, BUN > 5.4 mmol/l, ferritin > 1500.0 ng/ml, IgG < 12.5 g/l, IgM < 1.1 g/l, C4 < 0.3 g/l, and CD56 cell counts > 94.0 cells/µl were the independent risk factors of EBV infection in SFTS patients.

CONCLUSIONS

SFTS combined with EBV infection is associated with high morbidity and mortality. It is necessary to strengthen screening for EBV infection and its early predictive markers after admission in SFTS patients.

摘要

背景

在免疫功能低下的人群中,EB 病毒(EBV)可被重新激活并增殖,导致致命后果,但严重发热伴血小板减少综合征(SFTS)患者 EBV 感染的临床后果仍不确定。在本研究中,我们调查了 SFTS 患者 EBV 感染的感染率、影响因素和早期预测指标。

方法

本回顾性研究纳入了 2011 年 5 月至 2021 年 8 月在南京医科大学第一附属医院治疗的 SFTS 患者,并将其分为感染组和非感染组。我们比较了两组患者的人口统计学特征、临床表现和体征、实验室检查和预后,并通过接受者操作特征(ROC)曲线和逻辑回归探讨了 EBV 感染的危险因素。

结果

本研究共纳入 120 例接受 EBV-DNA 检测的住院 SFTS 患者。EBV 感染患者的死亡率有统计学显著升高(32.0% vs. 11.43%,P=0.005)。与非感染组相比,感染组的 C 反应蛋白(CRP)、肌酸激酶(CK)、空腹血糖(FBG)、血尿素氮(BUN)、D-二聚体和 CD56 细胞计数较高,免疫球蛋白 G(IgG)、IgM、补体 3(C3)和 C4 水平较低。感染组年龄≥60 岁和铁蛋白>1500.0ng/ml 的患者比例明显高于非感染组。ROC 分析结果显示,CRP、IgG、C3、C4 和 CD56 细胞计数的截断值分别为 13.2mg/l、12.5g/l、1.1g/l、0.6g/l、0.3g/l 和 94.0cells/µl。多变量逻辑分析显示,年龄≥60 岁、CRP>13.2mg/l、BUN>5.4mmol/l、铁蛋白>1500.0ng/ml、IgG<12.5g/l、IgM<1.1g/l、C4<0.3g/l 和 CD56 细胞计数>94.0cells/µl 是 SFTS 患者 EBV 感染的独立危险因素。

结论

SFTS 合并 EBV 感染与高发病率和死亡率相关。有必要加强 SFTS 患者入院后的 EBV 感染筛查及其早期预测标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2b3/11304918/3c00b0948d5e/12985_2024_2452_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2b3/11304918/e7f38d0cecf6/12985_2024_2452_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2b3/11304918/3c00b0948d5e/12985_2024_2452_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2b3/11304918/e7f38d0cecf6/12985_2024_2452_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2b3/11304918/3c00b0948d5e/12985_2024_2452_Fig2_HTML.jpg

相似文献

1
Early predictors of Epstein-Barr virus infection in patients with severe fever with thrombocytopenia syndrome.严重发热伴血小板减少综合征患者中 EB 病毒感染的早期预测因子。
Virol J. 2024 Aug 7;21(1):179. doi: 10.1186/s12985-024-02452-5.
2
Analysis of the epidemiology and clinical characteristics of Epstein-Barr virus infection.分析 Epstein-Barr 病毒感染的流行病学和临床特征。
J Med Virol. 2024 Oct;96(10):e29960. doi: 10.1002/jmv.29960.
3
Early-Warning Immune Predictors for Invasive Pulmonary Aspergillosis in Severe Patients With Severe Fever With Thrombocytopenia Syndrome.严重发热伴血小板减少综合征重症患者侵袭性肺曲霉病的预警免疫预测因子。
Front Immunol. 2021 May 7;12:576640. doi: 10.3389/fimmu.2021.576640. eCollection 2021.
4
Association between Epstein-Barr virus infection and serum positivity rate of anti-nuclear antibodies in Chongqing, China: A cross-sectional observational study.中国重庆 EB 病毒感染与血清抗核抗体阳性率的相关性:一项横断面观察性研究。
Medicine (Baltimore). 2024 Aug 9;103(32):e39233. doi: 10.1097/MD.0000000000039233.
5
Difference in hematocrit and plasma albumin levels as an early biomarker of severity and prognosis in patients with severe fever and thrombocytopenia syndrome.血细胞比容和血浆白蛋白水平的差异作为严重发热伴血小板减少综合征患者严重程度和预后的早期生物标志物。
J Med Virol. 2024 Oct;96(10):e29941. doi: 10.1002/jmv.29941.
6
Aspartate aminotransferase to platelet ratio correlates with poor prognosis and metabolic alterations in infection.天冬氨酸转氨酶与血小板比值与感染患者的不良预后及代谢改变相关。
Front Immunol. 2025 Jan 17;15:1471511. doi: 10.3389/fimmu.2024.1471511. eCollection 2024.
7
Characteristics of primary Epstein-Barr virus infection disease spectrum and its reactivation in children, in Suzhou, China.中国苏州儿童原发性 EBV 感染疾病谱及其再激活的特征。
J Med Virol. 2021 Aug;93(8):5048-5057. doi: 10.1002/jmv.26941. Epub 2021 Mar 25.
8
Plasma Epstein-Barr Virus DNA load for diagnostic and prognostic assessment in intestinal Epstein-Barr Virus infection.血浆爱泼斯坦-巴尔病毒DNA载量在肠道爱泼斯坦-巴尔病毒感染诊断及预后评估中的应用
Front Cell Infect Microbiol. 2025 Jan 7;14:1526633. doi: 10.3389/fcimb.2024.1526633. eCollection 2024.
9
The AST/ALT Ratio (De Ritis Ratio) Represents an Unfavorable Prognosis in Patients in Early-Stage SFTS: An Observational Cohort Study.AST/ALT 比值(De Ritis 比值)反映了早期发热伴血小板减少综合征患者的不良预后:一项观察性队列研究。
Front Cell Infect Microbiol. 2022 Feb 8;12:725642. doi: 10.3389/fcimb.2022.725642. eCollection 2022.
10
[Lung injury associated with severe Epstein-Barr virus (EBV) infection].[与严重爱泼斯坦-巴尔病毒(EBV)感染相关的肺损伤]
Zhonghua Er Ke Za Zhi. 2015 Aug;53(8):586-91.

本文引用的文献

1
TRIM3 attenuates cytokine storm caused by promoting Toll-like receptor 3 degradation.TRIM3通过促进Toll样受体3降解来减轻细胞因子风暴。
Front Microbiol. 2023 Jul 14;14:1209870. doi: 10.3389/fmicb.2023.1209870. eCollection 2023.
2
Fatal outcome of severe fever with thrombocytopenia syndrome (SFTS) and severe and critical COVID-19 is associated with the hyperproduction of IL-10 and IL-6 and the low production of TGF-β.严重发热伴血小板减少综合征(SFTS)和严重及危重新冠肺炎的致命结局与 IL-10 和 IL-6 的过度产生以及 TGF-β 的产生不足有关。
J Med Virol. 2023 Jul;95(7):e28894. doi: 10.1002/jmv.28894.
3
Application of blood purification technology in severe fever with thrombocytopenia syndrome.
血液净化技术在重型发热伴血小板减少综合征中的应用。
Biotechnol Genet Eng Rev. 2024 Dec;40(4):4943-4952. doi: 10.1080/02648725.2023.2219940. Epub 2023 May 30.
4
Ferritin and procalcitonin serve as discriminative inflammatory biomarkers and can predict the prognosis of severe fever with thrombocytopenia syndrome in its early stages.铁蛋白和降钙素原作为有鉴别意义的炎症生物标志物,可在早期预测严重发热伴血小板减少综合征的预后。
Front Microbiol. 2023 Apr 18;14:1168381. doi: 10.3389/fmicb.2023.1168381. eCollection 2023.
5
Risk Factors for Mortality in Severe Fever with Thrombocytopenia Syndrome Patients with Central Nervous System Complications.严重发热伴血小板减少综合征患者伴有中枢神经系统并发症的死亡危险因素。
Med Sci Monit. 2023 Mar 24;29:e938427. doi: 10.12659/MSM.938427.
6
Prognostic Value of Serum Ferritin for Patients with Severe Fever with Thrombocytopenia Syndrome: A Single-Center Retrospective Cohort Study.血清铁蛋白对严重发热伴血小板减少综合征患者的预后价值:一项单中心回顾性队列研究
Infect Dis Ther. 2023 Mar;12(3):979-988. doi: 10.1007/s40121-023-00784-3. Epub 2023 Mar 8.
7
Risk factors of severe fever with thrombocytopenia syndrome combined with central neurological complications: A five-year retrospective case-control study.发热伴血小板减少综合征合并中枢神经系统并发症的危险因素:一项五年回顾性病例对照研究。
Front Microbiol. 2022 Nov 3;13:1033946. doi: 10.3389/fmicb.2022.1033946. eCollection 2022.
8
Epstein-Barr virus: Biology and clinical disease.爱泼斯坦-巴尔病毒:生物学与临床疾病。
Cell. 2022 Sep 29;185(20):3652-3670. doi: 10.1016/j.cell.2022.08.026. Epub 2022 Sep 15.
9
Epstein-Barr virus antibody in newly diagnosed multiple sclerosis patients and its association with relapse severity and lesion location.新诊断多发性硬化症患者的 EB 病毒抗体及其与复发严重程度和病变位置的关系。
Mult Scler Relat Disord. 2022 Dec;68:104149. doi: 10.1016/j.msard.2022.104149. Epub 2022 Aug 28.
10
Transmission and mortality risk assessment of severe fever with thrombocytopenia syndrome in China: results from 11-years' study.中国发热伴血小板减少综合征的传播和病死率评估:11 年研究结果。
Infect Dis Poverty. 2022 Sep 4;11(1):93. doi: 10.1186/s40249-022-01017-4.